Amy C. Porter

3.1k total citations
35 papers, 2.3k citations indexed

About

Amy C. Porter is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Amy C. Porter has authored 35 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Pharmacology and 6 papers in Physiology. Recurrent topics in Amy C. Porter's work include Receptor Mechanisms and Signaling (8 papers), Cannabis and Cannabinoid Research (7 papers) and Biomedical Ethics and Regulation (4 papers). Amy C. Porter is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Cannabis and Cannabinoid Research (7 papers) and Biomedical Ethics and Regulation (4 papers). Amy C. Porter collaborates with scholars based in United States and Canada. Amy C. Porter's co-authors include Richard R. Vaillancourt, Christian C. Felder, Ruchira Sood, Ronald C. Wek, John‐Michael Sauer, Frank P. Bymaster, Douglas R. Cavener, Gary R. Fanger, Lawrence A. Quilliam and Kun Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Amy C. Porter

33 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy C. Porter United States	20	1.1k	939	677	338	206	35	2.3k
M. Grimaldi Italy	26	972 0.9×	884 0.9×	930 1.4×	160 0.5×	208 1.0×	79	2.7k
Teresa Gómez del Pulgar Spain	23	1.0k 0.9×	1.8k 1.9×	1.1k 1.6×	201 0.6×	442 2.1×	36	3.1k
Saori Oka Japan	26	954 0.8×	1.5k 1.6×	781 1.2×	170 0.5×	475 2.3×	52	2.7k
Raphaël Rozenfeld United States	20	1.2k 1.0×	556 0.6×	1.0k 1.5×	300 0.9×	242 1.2×	28	2.5k
Michael D. Knierman United States	24	1.5k 1.3×	459 0.5×	449 0.7×	129 0.4×	360 1.7×	43	3.2k
J.P. Maffrand France	29	1.3k 1.2×	873 0.9×	685 1.0×	138 0.4×	530 2.6×	56	3.9k
Nicole Defer France	30	2.2k 1.9×	263 0.3×	710 1.0×	196 0.6×	191 0.9×	81	3.1k
Tomoyuki Nishizaki Japan	29	1.3k 1.2×	218 0.2×	529 0.8×	214 0.6×	151 0.7×	120	2.7k
Yiming Jiang China	31	1.7k 1.5×	145 0.2×	470 0.7×	195 0.6×	173 0.8×	97	3.3k
Fabrizio Facchinetti Italy	25	664 0.6×	382 0.4×	464 0.7×	78 0.2×	79 0.4×	70	2.3k

Countries citing papers authored by Amy C. Porter

Since Specialization

Citations

This map shows the geographic impact of Amy C. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy C. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy C. Porter more than expected).

Fields of papers citing papers by Amy C. Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy C. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy C. Porter. The network helps show where Amy C. Porter may publish in the future.

Co-authorship network of co-authors of Amy C. Porter

This figure shows the co-authorship network connecting the top 25 collaborators of Amy C. Porter. A scholar is included among the top collaborators of Amy C. Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy C. Porter. Amy C. Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Valberg, Stephanie J. & Amy C. Porter. (2024). Skeletal Muscle Biopsy. Veterinary Clinics of North America Equine Practice. 41(1). 31–45.

Porter, Amy C., et al.. (2022). “On the Other Side of the Fence”: Impact of Personal Experiences on Career Path, Clinical Practice, and Professional Endurance Among Hospice Nurses Caring for Dying Children (S559). Journal of Pain and Symptom Management. 63(5). 938–939. 1 indexed citations

Sauer, John‐Michael & Amy C. Porter. (2021). Qualification of translational safety biomarkers. Experimental Biology and Medicine. 246(22). 2391–2398. 6 indexed citations

Schomaker, Shelli, David M. Potter, Roscoe L. Warner, et al.. (2020). Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments. PLoS ONE. 15(5). e0229753–e0229753. 44 indexed citations

Stegall, Mark D., Matthew J. Everly, Roslyn B. Mannon, et al.. (2018). The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium’s position statement. American Journal of Transplantation. 19(3). 625–632. 12 indexed citations

Sauer, John‐Michael & Amy C. Porter. (2017). Preclinical biomarker qualification. Experimental Biology and Medicine. 243(3). 222–227. 17 indexed citations

Hicks, Ramona, et al.. (2017). The 5th Annual One Mind Summit: Lessons Learned About “Science Informing Brain Health Policies and Practice”. Journal of Neurotrauma. 34(19). 2833–2839. 1 indexed citations

Rzasa, Robert M., Essa Hu, Ning Chen, et al.. (2012). Discovery of selective biaryl ethers as PDE10A inhibitors: Improvement in potency and mitigation of Pgp-mediated efflux. Bioorganic & Medicinal Chemistry Letters. 22(24). 7371–7375. 21 indexed citations

Gustin, Darin J., Zhihua Ma, Xiaoshan Min, et al.. (2011). Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(8). 2492–2496. 38 indexed citations

10.

Porter, Amy C., et al.. (2004). A Role for Caveolae/Lipid Rafts in the Uptake and Recycling of the Endogenous Cannabinoid Anandamide. Journal of Biological Chemistry. 279(40). 41991–41997. 110 indexed citations

11.

Porter, Amy C., Samuel Svensson, W. Daniel Stamer, et al.. (2003). Alpha-2 adrenergic receptors stimulate actin organization in developing fetal rat cardiac myocytes. Life Sciences. 72(13). 1455–1466. 14 indexed citations

12.

Porter, Amy C., John‐Michael Sauer, Michael D. Knierman, et al.. (2002). Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor. Journal of Pharmacology and Experimental Therapeutics. 301(3). 1020–1024. 441 indexed citations

13.

Porter, Amy C. & Christian C. Felder. (2001). The endocannabinoid nervous system. Pharmacology & Therapeutics. 90(1). 45–60. 189 indexed citations

14.

Stamer, W. Daniel, Yoshiaki Hosohata, Amy C. Porter, et al.. (2001). Cannabinoid CB1 receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues. European Journal of Pharmacology. 431(3). 277–286. 80 indexed citations

15.

Felder, Christian C., Amy C. Porter, Lu Zhang, et al.. (2001). Elucidating the role of muscarinic receptors in psychosis. Life Sciences. 68(22-23). 2605–2613. 97 indexed citations

16.

Sood, Ruchira, Amy C. Porter, Kun Ma, Lawrence A. Quilliam, & Ronald C. Wek. (2000). Pancreatic eukaryotic initiation factor-2α kinase (PEK) homologues in humans, Drosophila melanogaster and Caenorhabditis elegans that mediate translational control in response to endoplasmic reticulum stress. Biochemical Journal. 346(2). 281–281. 124 indexed citations

17.

Porter, Amy C., et al.. (1999). Diagnosing infectious diseases using in situ hybridization. Journal of Swine Health and Production. 7(3). 125–128. 3 indexed citations

18.

Porter, Amy C., Gary R. Fanger, & Richard R. Vaillancourt. (1999). Signal transduction pathways regulated by arsenate and arsenite. Oncogene. 18(54). 7794–7802. 69 indexed citations

19.

Fanger, Gary R., et al.. (1998). 14-3-3 Proteins Interact with Specific MEK Kinases. Journal of Biological Chemistry. 273(6). 3476–3483. 133 indexed citations

20.

Svensson, Samuel, Thomas J. Bailey, Amy C. Porter, Jeremy G. Richman, & John W. Regan. (1996). Heterologous expression of the cloned guinea pig α2A, α2B, and α2C adrenoceptor subtypes. Biochemical Pharmacology. 51(3). 291–300. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact